Pharma BD Deal Intelligence
Johnson & Johnson (Janssen Pharmaceutica) / Vertex Pharmaceuticals (telaprevir ex-NA/ex-Far East rights)
2006 · Asset Purchase · $545M · Complete
Announcement Sentiment
75
Strongly positive
HCV; $165M upfront + up to $380M milestones; Tibotec/Janssen got ex-NA, ex-Far East rights
Key facts
- Announced Jun 30, 2006
- Deal value $545M
- Deal type Asset Purchase
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals